Tokio Marine HCC - Stop Loss Group Enters the Level Funded Stop Loss Market

 
 
 
 
 
 
 

For over 45 years, Tokio Marine HCC – Stop Loss Group (TMHCC) has been a leading provider of medical stop loss insurance, Taft-Hartley, captive, and organ transplant solutions, provided through brokers, consultants, and third-party administrators. Rated A++ (Superior) by A.M. Best Company, AA- by Fitch Ratings (Very Strong), and A+ (Strong) by Standard and Poor’s, TMHCC is backed by the financial stability of its parent company, Tokio Marine HCC.

 
 

By listening to the demands of the market, we have developed exceptional products, unparalleled resources, and value-added services to set us apart in the industry.

 
 
For effective dates of January 1, 2023, TMHCC is pleased to announce a level funded, aggregate-only stop loss solution to help clients coming from fully insured insurance coverage control their healthcare costs.

With our Level Funded Stop Loss product, employers will receive the benefits of self-funding by keeping unused funds, while also receiving lower maximum costs, no lasers, flexibility in plan design and control of their health plans.

TMHCC is proud to partner with TPAC Underwriters (TPAC), capitalizing on their expertise, helping us with the day-to-day logistics of level funding. TPAC pioneered one of the first level funded products in the nation and has successfully helped employers establish a fixed monthly budget for claims coverage within the client’s self-funded health plan for almost 25 years.


*The Level Funded Stop Loss product is not available in all states.
 
 
 
 
 
 
Please contact your regional marketing representative to learn more about Level Funded Stop Loss.

 

Contact TMHCC